Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00481390
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2007-05-31
Brief Title:
Prospective Epidemiological Study Of The Prevalence Of HLA-B5701 In HIV-1 Infected Patients
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Study Overview
Official Title:
Prospective Epidemiological Study of the Prevalence of HLA-B5701 in HIV-1 Infected Patients
Status:
COMPLETED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a cross-sectional observational study to evaluate the prevalence of HLA-B5701 in the European area and in major European ethnotypes
Any HIV-1 infected patient will be eligible for this study including treatment naïve and experienced patients as well as patients previously tested for HLA-B5701 Patients will be approached during a standard clinic visit and will be consented prior to any study specific procedure They will be asked to provide a tissue sample cheek cells and blood sample which will be used to assess HLA-B5701 status by local and central laboratories
In selected sites patients may be asked to provide an additional blood sample This sample will be used to develop and validate different methodologies for assessing HLA-B5701 status
Any HIV-1 infected patient will be eligible for this study including treatment naïve and experienced patients as well as patients previously tested for HLA-B5701 Patients will be approached during a standard clinic visit and will be consented prior to any study specific procedure They will be asked to provide a tissue sample cheek cells and blood sample which will be used to assess HLA-B5701 status by local and central laboratories
In selected sites patients may be asked to provide an additional blood sample This sample will be used to develop and validate different methodologies for assessing HLA-B5701 status
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None